RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. European Investment Bank Group
E

European Investment Bank Group portfolio

European Investment Bank Group has 23 portfolio companies on record at Recent Funding, with 5 investments in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 23.
Deals, last 12 months: 5.
Capital in their rounds: $1.36B.
Latest deal: Nouscom · Oct 19, 2026.
About this page

Its most recent investment on record is Nouscom's $135.04M Series B+ round in October 2026, alongside EQT Life Sciences, Neva SGR, XGEN Venture and 6 others. By category, its portfolio leans toward Health and bio (10) and Manufacturing and industrial (6). It has co-invested with Neva SGR, Indaco Venture Partners and imec.xpand, most often Neva SGR (2 rounds).

What European Investment Bank Group invests in

European Investment Bank Group recent investments

CompanyRoundDateAlongside
NNouscomSeries B+ · $135.04MEQT Life Sciences, Neva SGR, XGEN Venture +6
RRougeTxSeries A · $58MEpidarex Capital, Angelini Ventures (lead), Kerna Ventures +6
MMorphotonicsSeries B+ · $45.85MInnovation Industries, Invest-NL (lead), BOM +3
EExeinSeries B+ · $270MGoldman Sachs, Headline (lead), Geodesic Capital +10
NNEURA RoboticsSeries B+Tether (lead), Bosch, Nvidia +6
AAerospacelabSeries B+ · $110MAirbus Ventures, XAnge, BNP Paribas Fortis +5
DD-OrbitSeries B+ · $167.37MIberis Capital, Marubeni America Corporation (lead), Neva SGR +6
QQontoSeries B+ · $550MValar Ventures, Guillaume Pousaz, TCV (lead) +6

How European Investment Bank Group invests

StageDealsCapital in rounds
Series B+ 8 89%$1.3B
Series A 1 11%$58M
YearDealsCapital in rounds
2018 1 11%$23M
2022 1 11%$550M
2024 1 11%$167.37M
2025 1 11%$110M
2026 5 56%$508.89M

European Investment Bank Group portfolio companies

CompanyRound with European Investment Bank GroupTotal raisedLatest raise
NNouscom
Health and bio
Series B+ · $135.04M$267.56MOct 19, 2026
Series B+
RRougeTx
Health and bio
Series A · $58M$58MOct 6, 2026
Series A
MMorphotonics
Robotics and hardware
Series B+ · $45.85M$55.85MSep 22, 2026
Series B+
EExein
AI agents
Series B+ · $270M$494.12MSep 15, 2026
Series B+
NNEURA Robotics
Health and bio
Series B+$192MJun 11, 2026
Series B+
AAerospacelab
Robotics and hardware
Series B+ · $110M$155.49MSep 24, 2025
Series B+
DD-Orbit
Logistics and mobility
Series B+ · $167.37M$330.37MJan 22, 2026
Series B+
QQonto
Fintech
Series B+ · $550M$701MJan 11, 2022
Series B+
MMMI
Health and bio
backer$310MOct 8, 2026
Series B+
FF2G
Health and bio
backer$100MSep 12, 2024
Series B+
KKinexon
Logistics and mobility
backer$130MApr 26, 2022
Series A
CCabify
Logistics and mobility
backerundisclosed—
FFormo
Commerce and retail
backer$111MOct 9, 2024
Series B+
TTissium
Health and bio
backer$241.14MJun 23, 2026
Series B+
EEavor
Climate and energy
backer$49.19MJun 3, 2025
Series B+
IImpress
Health and bio
backer$155.89MJul 11, 2022
Series B+
SSwappie
Commerce and retail
backer$162.73MFeb 15, 2022
Series B+
EEnergy Dome
Climate and energy
backer$72MJul 1, 2023
Series B+
SSennder
Logistics and mobility
backer$483.7MNov 11, 2026
round
SSidekick Health
Health and bio
backer$75MMay 10, 2022
Series B+
GGROPYUS
Real estate and construction
backer$32MSep 23, 2025
Series B+
MmiDiagnostics
Health and bio
backer$34.88MDec 4, 2024
Series B+
SStark Future
Logistics and mobility
backer$170.71MNov 16, 2026
round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 9 rounds on Recent Funding that name European Investment Bank Group. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists European Investment Bank Group, which is a subset of its real portfolio. API: /api/v1/investors/european-investment-bank-group (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy